483
Wuxi Fortune Pharmaceutical Co., Ltd.FDA 483 - Wuxi Fortune Pharmaceutical Co., Ltd. - September 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Wuxi Fortune Pharmaceutical Co., Ltd in Wuxi City, China, revealed significant deficiencies in their manufacturing processes. Observations included a lack of qualification for critical manufacturing equipment and systems, and failures to record and justify deviations from written production procedures. Additionally, the firm did not perform identity and quality testing for incoming Active Pharmaceutical Ingredient (API).
Open in Dashboard
ID · df20d95e-9b02-48b4-a766-693c46f26888